Epitomee Medical Ltd
EPTMF
$0.9892
-$0.0327-3.20%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.79M | -1.79M | -2.30M | -2.68M | -2.68M |
| Total Depreciation and Amortization | 223.00K | 223.00K | -317.00K | 99.00K | 99.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -364.00K | -364.00K | 414.00K | 454.50K | 454.50K |
| Change in Net Operating Assets | -22.50K | -22.50K | 227.00K | -40.50K | -40.50K |
| Cash from Operations | -1.95M | -1.95M | -1.97M | -2.17M | -2.17M |
| Capital Expenditure | -462.00K | -462.00K | -914.00K | -377.50K | -377.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.91M | 2.91M | 6.88M | 1.31M | 1.31M |
| Cash from Investing | 2.45M | 2.45M | 5.96M | 931.00K | 931.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -157.50K | -157.50K | -148.00K | -116.50K | -116.50K |
| Issuance of Common Stock | 25.50K | 25.50K | 1.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -132.00K | -132.00K | -147.00K | -116.50K | -116.50K |
| Foreign Exchange rate Adjustments | 478.00K | 478.00K | -400.00K | -207.50K | -207.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 841.00K | 841.00K | 3.45M | -1.56M | -1.56M |